← Evidence map

ArticleFrontiers in microbiology2022

An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients.

Minghui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 36110295